Recruiting pediatric patients for type 2 diabetes mellitus (T2DM) studies is extremely challenging. Patients are difficult to identify and often face socio-economic or domestic challenges that can prevent clinical trial participation. These trials typically exceed planned recruitment timelines by years, and previous programs for this sponsor were cancelled due to low enrollment. To mitigate these known study risks, PRA commissioned our Site Engagement team early in the study-planning phase to help sites develop customized recruitment initiatives to strictly maintain enrollment timelines.
You may also be interested in:
Blog
Thyroid Awareness Month: Why these Common Conditions are Difficult to Diagnose
For Thyroid Awareness Month this January, we share information about the latest research and treatments available for this endocrine condition.
Blog
Ask the Experts: What Can We Do to Stop the Progression of Diabetes Worldwide?
Diabetes is a disease that occurs when your blood sugar levels are too high. That blood sugar, known as glucose, is what gives your cells energy. The…
Blog
A Patient’s Perspective: Living with Type 1 Diabetes
Diabetes is a condition in which the body is unable to produce or properly utilize insulin, a hormone which is essential for energy production from…